Cardiometabolic Effects of Eplerenone in HIV Infection

NCT02629094 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Cardiac Steatosis
Hepatic Steatosis

Interventions

DRUG: Inspra /Eplerenone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)